These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 32385167
1. The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study. Harsini S, Saprunoff H, Alden T, Mohammadi B, Wilson D, Bénard F. J Nucl Med; 2021 Jan; 62(1):81-87. PubMed ID: 32385167 [Abstract] [Full Text] [Related]
2. Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL in peripheral ganglia. Werner RA, Sheikhbahaei S, Jones KM, Javadi MS, Solnes LB, Ross AE, Allaf ME, Pienta KJ, Lapa C, Buck AK, Higuchi T, Pomper MG, Gorin MA, Rowe SP. Ann Nucl Med; 2017 Nov; 31(9):696-702. PubMed ID: 28831739 [Abstract] [Full Text] [Related]
3. Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ Uptake. Li X, Rowe SP, Leal JP, Gorin MA, Allaf ME, Ross AE, Pienta KJ, Lodge MA, Pomper MG. J Nucl Med; 2017 Jun; 58(6):942-946. PubMed ID: 27932557 [Abstract] [Full Text] [Related]
9. Monosodium Glutamate Reduces 68Ga-PSMA-11 Uptake in Salivary Glands and Kidneys in a Preclinical Prostate Cancer Model. Rousseau E, Lau J, Kuo HT, Zhang Z, Merkens H, Hundal-Jabal N, Colpo N, Lin KS, Bénard F. J Nucl Med; 2018 Dec; 59(12):1865-1868. PubMed ID: 30097503 [Abstract] [Full Text] [Related]
10. A Prospective Study on 18F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer. Rousseau E, Wilson D, Lacroix-Poisson F, Krauze A, Chi K, Gleave M, McKenzie M, Tyldesley S, Goldenberg SL, Bénard F. J Nucl Med; 2019 Nov; 60(11):1587-1593. PubMed ID: 30979820 [Abstract] [Full Text] [Related]
17. Heterogeneous PSMA ligand uptake inside parotid glands. Sample CM, Uribe C, Rahmim A, Bénard F, Wu J, Clark H. Phys Med; 2024 May; 121():103366. PubMed ID: 38657425 [Abstract] [Full Text] [Related]
18. 18F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smoothing Filter, and Partial-Volume Correction on PROMISE Criteria. Ortega C, Schaefferkoetter J, Veit-Haibach P, Anconina R, Berlin A, Perlis N, Metser U. J Nucl Med; 2020 Nov; 61(11):1615-1620. PubMed ID: 32198311 [Abstract] [Full Text] [Related]
20. Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management. Song H, Harrison C, Duan H, Guja K, Hatami N, Franc BL, Moradi F, Aparici CM, Davidzon GA, Iagaru A. J Nucl Med; 2020 Apr; 61(4):546-551. PubMed ID: 31628216 [Abstract] [Full Text] [Related] Page: [Next] [New Search]